UK markets closed

Genor Biopharma Holdings Limited (6998.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.250-0.030 (-2.34%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
15,932
0
10,331
Cost of revenue
0
0
983
0
2,596
Gross profit
0
0
14,949
0
7,735
Operating expenses
Research development
564,278
564,278
583,881
612,718
696,574
Selling general and administrative
125,237
125,237
217,273
305,953
241,440
Total operating expenses
689,515
689,515
801,154
918,671
932,156
Operating income or loss
-689,515
-689,515
-786,205
-918,671
-924,421
Interest expense
888
888
2,856
2,362
5,539
Income before tax
-677,496
-677,496
-732,420
-866,306
-3,036,310
Income tax expense
-2,280
-2,280
-2,024
-932
-5,806
Income from continuing operations
-675,216
-675,216
-730,396
-865,374
-3,030,504
Net income
-674,362
-674,362
-730,214
-865,224
-3,027,102
Net income available to common shareholders
-674,362
-674,362
-730,214
-865,224
-3,027,102
Basic EPS
-1.18
-1.33
-1.45
-1.75
-12.36
Diluted EPS
-1.18
-1.33
-1.45
-1.77
-12.36
Basic average shares
507,563
506,245
504,301
495,180
244,890
Diluted average shares
507,818
506,245
504,301
496,203
244,890